SCHEMBL24673319

SCHEMBL24673319

CCCCCCC(CCC)CNCCCCCCCCCC(CC)CCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.53
TSHR P16473 2/20 0.53
CYP3A4 P08684 1/20 0.53
ANPEP P15144 1/20 0.41
ERAP2 Q6P179 1/20 0.41
LMNA P02545 1/20 0.41
EPHX1 P07099 2/20 0.36
ADH1B P00325 2/20 0.36
ADH1C P00326 2/20 0.36
ADH1A P07327 2/20 0.36
ADH4 P08319 2/20 0.36
ADH7 P40394 2/20 0.36
KDM4E B2RXH2 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
OPRM1 P35372 1/20 0.34
S1PR2 O95136 5/20 0.34
S1PR4 O95977 5/20 0.34
S1PR1 P21453 5/20 0.34
S1PR3 Q99500 5/20 0.34
CA2 P00918 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25781929 0.94 TSHR (0.48) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL21790678 0.93 ALDH1A1 (0.53) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL22861921 0.91 ALDH1A1 (0.50) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL20627942 0.90 ALDH1A1 (0.65) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL9212067 0.90 ALDH1A1 (0.59) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL9202558 0.90 ALDH1A1 (0.54) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL11663393 0.90 ALDH1A1 (0.65) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL11660748 0.90 ALDH1A1 (0.65) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL26741197 0.90 TSHR (0.52) ALDH1A1TSHRCYP3A4ANPEPERAP2
SCHEMBL26741304 0.90 TSHR (0.52) ALDH1A1TSHRCYP3A4ANPEPERAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220340570-A1 IRAK DEGRADERS AND USES THEREOF KYMERA THERAPEUTICS, INC. 2022-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220340570-A1 IRAK DEGRADERS AND USES THEREOF IRAK2, IRAK3, IRAK1 ALDH1A1 2776/4885TSHR 3319/4885CYP3A4 2542/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.